SCHEMBL13924801

SCHEMBL13924801

C=C1c2ccc(Cl)cc2C(=O)c2oc(CC)cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S100A4 P26447 2/20 0.42
▸ METAP1 P53582 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ PPOX P50336 1/20 0.33
▸ USP8 P40818 1/20 0.31
▸ USP7 Q93009 1/20 0.31
▸ USP47 Q96K76 1/20 0.31
▸ NOTUM Q6P988 1/20 0.31
▸ CES1 P23141 2/20 0.30
▸ NPC1 O15118 2/20 0.30
▸ ALDH1A1 P00352 2/20 0.30
▸ MAPK1 P28482 2/20 0.30
▸ RAB9A P51151 2/20 0.30
▸ SMN1; SMN2 Q16637 2/20 0.30
▸ LMNA P02545 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ TGM2 P21980 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12640076 0.87 S100A4 (0.46) S100A4HSP90AA1PPOXUSP8USP7
SCHEMBL18030271 0.82 ALDH1A1 (0.43) NPC1ALDH1A1MAPK1RAB9ASMN1; SMN2
SCHEMBL13925108 0.78 STAT3 (0.52) S100A4METAP1HSP90AA1PPOXALDH1A1
SCHEMBL13699055 0.75 S100A4 (0.67) S100A4METAP1HSP90AA1PPOXUSP8
SCHEMBL13924796 0.72 IDO1 (0.42) S100A4ALDH1A1MAPK1LMNAMAPT
SCHEMBL12640078 0.70 ALDH1A1 (0.39) USP8USP7USP47NPC1ALDH1A1
SCHEMBL29362087 0.69 ALDH1A1 (0.56) S100A4USP8USP7CES1NPC1
SCHEMBL1885714 0.69 ALDH1A1 (0.56) S100A4USP8USP7CES1NPC1
SCHEMBL13924973 0.69 STAT3 (0.41) ALDH1A1MAPK1
SCHEMBL10924194 0.67 S100A4 (0.50) S100A4METAP1HSP90AA1PPOXCES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2194987-B1 NOVEL STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL INHIBITORS BOSTON BIOMEDICAL INC (US) 2016-05-18 — — EP disclosed
WO-2009036059-A2 NOVEL STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL INHIBITORS BOSTON BIOMEDICAL, INC. (US) 2009-03-19 — — WO disclosed
Send feedback